Forest Ray - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Forest Ray's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Forest Ray
Verified
Science Writer, BioNews Services
Long Beach, Los Angeles
Beats
Biography
Science and sometimes investigative journalist, covering the intersections of science, ecology and everyday life.
Gambling, sports
Content
The G protein modifier KCTD5 tunes the decoding of neuromodulatory signals necessary for motor function in striatal neurons
By Douglas Sloan, Yini Liao, Forest Ray Verified, Brian S. Muntean| PLOS Biology Verified MethodsExperimental protocols were approved by Augusta University’s Institutional Animal Care and Use Committee (Animal Use Protocol 2020-1036) and Institutional Biosafety Committee (Biosafety Protocol #2037). Mice were housed under standard conditions on a 12-hour light/dark cycle with unlimited access to both food and water.
By Forest Ray Verified| 360Dx Verified NEW YORK – A new low-cost tuberculosis (TB) test that requires no lab facilities and little specialist training might be able to help fill healthcare gaps in remote and low-resource settings. The Lab-in-a-Tube TB (LIT-TB) test is being developed by scientists at Tulane University, who published the results of a pilot study of the device yesterday in Science Translational Medicine.
By Forest Ray Verified| 360Dx Verified NEW YORK – As Republican legislators in the US Congress look to slash Medicaid, the Rare Disease Advisory Council (RDAC) of Minnesota thinks that it has found a way to improve Medicaid access for newborns with rare diseases. Along with several collaborators, the Minnesota RDAC has proposed a bill, SF 1175, that would make children automatically –– or presumptively, in legal phrasing –– eligible for Medicaid disability coverage based on the results of newborn screening (NBS).
Company Info
BioNews Services
Bionews, Inc. is a digital health solutions company based in Delaware, founded in 2013. It specializes in supporting rare disease communities through over 68 health media websites, which serve more than 500,000 registered members. The company is committed to authenticity, with over half of its team having personal experience with rare diseases as patients or caregivers. Bionews connects patients, caregivers, and healthcare stakeholders by providing trusted news, clinical updates, and community resources. Its services include digital media platforms that offer condition-specific content, community engagement through forums and advocacy resources, and content development featuring articles, podcasts, and videos. The company also tracks user engagement and provides analytics to support client campaigns. Bionews collaborates with biotech, life sciences, and healthcare companies to enhance marketing and patient engagement in the rare disease sector.
'+1 800-936-1363
Founded: 2013